Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Intangibles (2016 - 2026)

Orthofix Medical has reported Intangibles over the past 17 years, most recently at $69.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Intangibles fell 14.62% year-over-year to $69.3 million, compared with a TTM value of $69.3 million through Mar 2026, down 14.62%, and an annual FY2025 reading of $72.8 million, down 26.35% over the prior year.
  • Intangibles came in at $69.3 million for Q1 2026, down from $72.8 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $126.0 million in Q2 2023 to a low of $47.5 million in Q3 2022.
  • Median Intangibles over the past 5 years was $98.8 million (2024), compared with a mean of $91.9 million.
  • The sharpest move saw Intangibles skyrocketed 154.71% in 2023, then decreased 27.98% in 2025.
  • Over 5 years, Intangibles stood at $124.8 million in 2022, then fell by 5.89% to $117.5 million in 2023, then fell by 15.91% to $98.8 million in 2024, then decreased by 26.35% to $72.8 million in 2025, then decreased by 4.71% to $69.3 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Intangibles are $69.3 million (Q1 2026), $72.8 million (Q4 2025), and $75.6 million (Q3 2025).